Condensed Interim Consolidated Balance Sheets - USD ($)	Jan. 31, 2022	Apr. 30, 2021
Current Assets:
Cash	$ 24,777	$ 144,129
Restricted cash held in trust	354,829	555,648
Accounts receivable		583
Subscription receivable		27,300
Prepayments and other receivables	4,195	6,852
Total current assets	383,801	734,512
TOTAL ASSETS	383,801	734,512
Current liabilities:
Accounts payable and accrued liabilities to third parties	38,739	129,021
Accounts payable and accrued liabilities to a related party	374,569	249,400
Demand loans	84,423	89,838
Loans from related parties	95,267	101,377
Amount due to related parties	190,096	49,064
Total current liabilities	783,094	618,700
Long term payable to a related party	117,714	229,504
Total Liabilities	900,808	848,204
STOCKHOLDERS’ DEFICIENCY
Class A Preferred stock, $0.001 par value, 5,000,000 authorized as at January 31, 2022 and April 30, 2021, respectively. Issued and outstanding shares: Nil and 24,371 as at January 31, 2022 and April 30, 2021, respectively.		24
Class B Preferred stock, $0.001 par value, 5,000,000 authorized as at January 31, 2022 and April 30, 2021, respectively. Issued and outstanding shares: Nil and 31,500 as at January 31, 2022 and April 30, 2021, respectively.
Common stock, $0.01 par value, 250,000,000 authorized as at January 31, 2022 and April 30, 2021, respectively. Issued and outstanding common shares: 95,655,183 and 47,295,183 as at January 31, 2022 and April 30, 2021, respectively.	533,091	252,951
Shares to be issued (2,118,000 and 420,000 common shares at January 31, 2022 and April 30, 2021 respectively)	148,260	27,300
Additional paid-in capital	3,769,737	3,948,919
Accumulated other comprehensive loss	(274,718)	(284,946)
Accumulated deficit	(4,173,274)	(3,583,385)
TOTAL EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY	3,096	360,863
TOTAL DEFICIT ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	(868,846)	(823,298)
LEGAL RESERVE	348,743	348,743
TOTAL DEFICIT	(517,007)	(113,692)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	$ 383,801	$ 734,512